Semaglutide is a GLP-1 receptor agonist, originally developed for type 2 diabetes and now FDA-approved for chronic weight management
They do offer an initial pricing of $199 during your first month, but then it increases to at least $249
For example, they might switch from a 2.5 mg/mL vial to a 5 mg/mL vial
Adequate hydration (at least 64 ounces of water daily), fiber-rich foods, regular physical activity, and over-the-counter fiber supplements can help maintain regularity
There appears to be no major difference between the results of the injectable versus pill form of the medication
The SELECT trial establishing semaglutides 20% reduction in major adverse cardiovascular events has converted GLP-1 receptor agonists from single-indication obesity drugs into foundational chronic disease therapeutics demanding continuous prescription renewal